Hydroxy acids and derivatives
Medchemexpress LLC Brimonidine tartrate (Synonyms: UK 14304 tartrate; AGN190342 tartrate) Solution10 mM * 1 mL in DMSO
Brimonidine tartrate (UK 14304 tartrate) is a full α2-adrenergic receptor (α2-AR) agonist.
Apexbio Technology LLC Ifenprodil Tartrate 23210-58-4 10mM (in 1mL DMSO)
Ifenprodil Tartrate (CAS 23210-58-4) is a small molecule recognized as an atypical noncompetitive antagonist of the NMDA (N-methyl-D-aspartate) receptor It demonstrates high-affinity binding to a uniform population of NMDA receptors in neonatal rat forebrain tissue exhibiting an IC50 value of 0 3 M By selectively modulating NMDA receptor activity Ifenprodil Tartrate serves as a valuable tool in neuropharmacological research particularly for investigating glutamatergic neurotransmission excitotoxicity and the roles of NMDA receptor subtypes in neuronal development and pathology
Medchemexpress LLC 3-Hydroxybutyric acid | 300-85-6 | 99.3% | 104.10 | 1 ML
3-Hydroxybutyric acid (β-Hydroxybutyric acid) is a metabolite that is elevated in type I diabetes. It can modulate the properties of membrane lipids.
- For research use only, not for sale to patients.
- Modulates properties of membrane lipids.
- Interacts with lipids and alters phase behavior.
- Diminishes interfacial viscosity of DPPC monolayers.
- Solid below 33°C, liquid above 34°C.
- Off-white to light yellow color.
- Store at 4°C, sealed, away from moisture.
- Store in solvent at -80°C for 6 months or -20°C for 1 month, sealed, away from moisture.
- Chemical formula: C4H8O3.
- Classified as ketones, aldehydes, and acids.
- Originates from microorganisms or as an endogenous metabolite.
- Ships at room temperature in continental US.
Medchemexpress LLC 2-Hydroxybutyric acid | 600-15-7 | 98.0% | 104.10 | 1 ML
2-Hydroxybutyric acid (α-Hydroxybutyric acid) is an endogenous metabolite converted from 2-Aminobutyric acid, with 2-oxobutyric acid as an intermediate. It is recognized as a potential biomarker for type 2 diabetes and preeclampsia. It has also been shown to prevent acetaminophen (AP)-induced liver injury.
- Derived from 2-Aminobutyric acid.
- Potential biomarker for type 2 diabetes and preeclampsia.
- Prevents acetaminophen-induced liver injury.
- Synthesized as a co-product of insulin resistance.
- Enhances cell viabilities and reduces AP-induced cytotoxicities in studies.
- Administration in C57 mice prevented AP-induced liver injury and normalized gene expression.
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | 100.0% | C17H19N3O6 | 1 ML
Varenicline tartrate is the tartrate salt of varenicline, a nicotinic acetylcholine receptor ligand used in research as a partial agonist of α4β2 nAChR. Supplied as a 10 mM solution in DMSO, this product is intended for laboratory research and analytical applications and is not for human use.
- Ready-to-use 10 mM solution in DMSO.
- High purity (99.96%) suitable for analytical applications.
- Small 1 mL vial minimizes freeze-thaw and waste.
- Validated for receptor pharmacology and in vitro assays.
- Stable when stored under recommended conditions.
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | MFCD08460603 | 100.0% | 361.127 Da | C17H19N3O6 | 25 MG
Varenicline tartrate is the tartrate salt of varenicline supplied as an analytical research standard for studies of nicotinic acetylcholine receptor pharmacology and nicotine dependence. It is an orally active partial agonist at α4β2 nicotinic acetylcholine receptors, provided as a high-purity solid suitable for analytical and pharmacological applications.
- High purity suitable for analytical use.
- Solid form for easy handling and storage.
- Suitable for receptor pharmacology and nicotine dependence studies.
- Provided as an analytical standard for quantitative assays.
- Available in 25 mg pack sizes for small-scale research.